| 11.38 -0.05 (-0.44%) | 09-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.61 | 1-year : | 14.01 |
| Resists | First : | 11.66 | Second : | 12 |
| Pivot price | 11.44  |
|||
| Supports | First : | 11.1 | Second : | 9.24 |
| MAs | MA(5) : | 11.4 |
MA(20) : | 11.45 |
| MA(100) : | 11.55  |
MA(250) : | 10.15 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 61.3 |
D(3) : | 67.1 |
| RSI | RSI(14): 40.4 | |||
| 52-week | High : | 12.44 | Low : | 7.28 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ SSIC ] has closed above bottom band by 17.5%. Bollinger Bands are 70.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 11.51 - 11.56 | 11.56 - 11.61 |
| Low: | 11.22 - 11.3 | 11.3 - 11.36 |
| Close: | 11.27 - 11.39 | 11.39 - 11.48 |
Silver Spike Investment Corp., is a a business development company. It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies. It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies. The company was founded in 2021 and is based in New York, New York.
Fri, 13 Sep 2024
Silver Spike Investment Corp. (NASDAQ:SSIC) Sees Significant Decrease in Short Interest - MarketBeat
Wed, 11 Sep 2024
Where are the Opportunities in (SSIC) - Stock Traders Daily
Fri, 05 Jul 2024
Chicago Atlantic Real Estate Finance's Stock Valuation & Dividend Yield Are Leaving Competitors Behind - Benzinga
Tue, 02 Jul 2024
Cookies sued for $2M over held-up Massachusetts dispensary deal - Green Market Report
Mon, 24 Jun 2024
Silver Spike Investment: Potential Gem's 8% Yield Not As Risky As It Seems (NASDAQ:SSIC) - Seeking Alpha
Sat, 11 May 2024
Silver Spike Investment Corp. (NASDAQ:SSIC) Q1 2024 Earnings Call Transcript - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 6 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 76.1 (%) |
| Shares Short | 10 (K) |
| Shares Short P.Month | 22 (K) |
| EPS | 0.89 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.56 |
| Profit Margin | 44.9 % |
| Operating Margin | 66.8 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 6.4 % |
| Qtrly Rev. Growth | 6.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 2 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 6.6 % |
| Operating Cash Flow | 13 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | 12.64 |
| PEG Ratio | 0 |
| Price to Book value | 0.83 |
| Price to Sales | 5.69 |
| Price to Cash Flow | 5.62 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 2.1% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|